Profile
Mark J.
Gergen is an Independent Director at Aristea Therapeutics, Inc. He previously served as the Executive Chairman at Poseida Therapeutics, Inc. from 2024 to 2025.
Mark also held positions as a Director at Aperio Technologies, Inc., Chief Financial & Development Officer at Advanced Tissue Sciences, Inc. from 1999 to 2003, and Senior Vice President-Corporate Development at Amylin Pharmaceuticals, Inc. from 2005 to 2012.
He was also a Principal at Jostens, Inc. and Medtronic, Inc. Mark served as the Chief Operating Officer & Senior Vice President at Halozyme Therapeutics, Inc. from 2016 to 2017, and as the Executive Vice President at CardioNet LLC from 2003 to 2005.
He was also a Principal at Premier Healthcare Solutions, Inc. and served as the Chief Operating Officer, Secretary & Executive VP at Mirati Therapeutics, Inc. in 2016.
Mr. Gergen obtained his undergraduate degree from Minot State University and his graduate degree from The University of Minnesota Law School.
Former positions of Mark Gergen
| Companies | Position | End |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Chief Executive Officer | 2023-12-31 |
| HALOZYME THERAPEUTICS, INC. | Chief Operating Officer | 2017-09-28 |
| MIRATI THERAPEUTICS | Chief Operating Officer | 2016-09-15 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | 2012-10-31 |
CardioNet LLC
CardioNet LLC Medical SpecialtiesHealth Technology Provides cardiac monitoring services | Corporate Officer/Principal | 2005-02-28 |
Training of Mark Gergen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Advanced Tissue Sciences, Inc.
Advanced Tissue Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human-based tissue products for therapeutic applications | Commercial Services |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Jostens, Inc.
Jostens, Inc. Commercial Printing/FormsCommercial Services Manufactures and sells yearbooks, graduation regalia, class jewelry and championship rings through online | Commercial Services |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Aperio Technologies, Inc.
Aperio Technologies, Inc. Medical SpecialtiesHealth Technology Provides digital pathology systems and services | Health Technology |
CardioNet LLC
CardioNet LLC Medical SpecialtiesHealth Technology Provides cardiac monitoring services | Health Technology |
Premier Healthcare Solutions, Inc.
Premier Healthcare Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides health care management consulting services | Commercial Services |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Minot State University
Minot State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Minnesota Law School
The University of Minnesota Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Aristea Therapeutics, Inc.
Aristea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies to treat serious inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Mark Gergen
















